DNA methylation landscape reveals GNAS as a decitabine-responsive marker in patients with acute myeloid leukemia
Background: The demethylation agent decitabine (DAC) is a pivotal non-intensive alternative treatment for acute myeloid leukemia (AML). However, patient responses to DAC are highly variable, and predictive biomarkers are warranted. Herein, the DNA methylation landscape of patients treated with a DAC...
Gardado en:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Elsevier
2024-03-01
|
| Series: | Neoplasia: An International Journal for Oncology Research |
| Assuntos: | |
| Acceso en liña: | http://www.sciencedirect.com/science/article/pii/S1476558624000022 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|